Yekaterina Chudnovsky
Directeur/Membre du Conseil chez ELICIO THERAPEUTICS, INC.
Fortune : 7 M $ au 30/04/2024
Postes actifs de Yekaterina Chudnovsky
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ELICIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/10/2022 | - |
| Independent Dir/Board Member | 01/10/2022 | - | |
| IMMIX BIOPHARMA, INC. | Directeur/Membre du Conseil | 22/08/2023 | - |
| Independent Dir/Board Member | 22/08/2023 | - | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Directeur/Membre du Conseil | - | - |
| Gkcc LLC | Directeur/Membre du Conseil | - | - |
Historique de carrière de Yekaterina Chudnovsky
Formation de Yekaterina Chudnovsky
| Northwestern University | Undergraduate Degree |
| DePaul University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELICIO THERAPEUTICS, INC. | Health Technology |
| IMMIX BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
xCures, Inc.
xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Technology Services |
| Gkcc LLC |
- Bourse
- Insiders
- Yekaterina Chudnovsky
- Expérience
